| Nome |
# |
|
Rethinking Idiopathic Pulmonary Fibrosis, file 0eb3c659-de48-475a-ae3f-07f353a12ea0
|
899
|
|
Pulmonary fibrosis: "idiopathic" is not "cryptogenic", file dfe4d22c-083b-bb0a-e053-d805fe0a78d9
|
813
|
|
The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study, file dfe4d22c-2cbb-bb0a-e053-d805fe0a78d9
|
532
|
|
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists, file dfe4d22d-ae3e-bb0a-e053-d805fe0a78d9
|
380
|
|
NANOFAT 2.0: experimental evidence for a fat grafting rich in mesenchymal stem cells., file dfe4d229-3241-bb0a-e053-d805fe0a78d9
|
256
|
|
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT, file dfe4d22d-af28-bb0a-e053-d805fe0a78d9
|
147
|
|
HRCT patterns of drug-induced interstitial lung diseases: A review, file dfe4d22d-ae3a-bb0a-e053-d805fe0a78d9
|
138
|
|
Idiopathic pulmonary fibrosis and cancer: do they really look similar?, file dfe4d22a-ce87-bb0a-e053-d805fe0a78d9
|
78
|
|
Semeiotica HRCT del pattern cistico nelle patologie polmonari, file dfe4d227-859f-bb0a-e053-d805fe0a78d9
|
66
|
|
High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children, file 6effd240-48c5-4fb9-882d-f8220478160c
|
47
|
|
Preventive and therapeutic effects of Thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis., file dfe4d22b-d414-bb0a-e053-d805fe0a78d9
|
40
|
|
Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases, file dfe4d22b-708e-bb0a-e053-d805fe0a78d9
|
39
|
|
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases, file dfe4d22d-8f7c-bb0a-e053-d805fe0a78d9
|
33
|
|
Complications in idiopathic pulmonary fibrosis: Focus on their clinical and radiological features, file dfe4d22d-8db7-bb0a-e053-d805fe0a78d9
|
32
|
|
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities, file dfe4d22d-eee6-bb0a-e053-d805fe0a78d9
|
31
|
|
PerFECT 2.0: A Web-Based Platform Designed to Facilitate and Support the Diagnosis of Patients with Idiopathic Pulmonary Fibrosis in Italy, file dfe4d22e-5d4f-bb0a-e053-d805fe0a78d9
|
29
|
|
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT, file dfe4d22d-ae38-bb0a-e053-d805fe0a78d9
|
25
|
|
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases, file dfe4d22d-8dc1-bb0a-e053-d805fe0a78d9
|
21
|
|
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay, file b2c3012d-a259-424b-9a63-cd188f3eb4ad
|
20
|
|
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series, file dfe4d22b-c3dc-bb0a-e053-d805fe0a78d9
|
19
|
|
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes, file dfe4d22c-2e64-bb0a-e053-d805fe0a78d9
|
19
|
|
The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus, file dfe4d22e-6785-bb0a-e053-d805fe0a78d9
|
19
|
|
Astrocytes modify migration of pbmcs induced by β-amyloid in a blood-brain barrier in vitro model, file dfe4d229-e75f-bb0a-e053-d805fe0a78d9
|
17
|
|
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?, file dfe4d22b-0b16-bb0a-e053-d805fe0a78d9
|
17
|
|
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients, file dfe4d22b-a907-bb0a-e053-d805fe0a78d9
|
17
|
|
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study., file dfe4d22b-a864-bb0a-e053-d805fe0a78d9
|
15
|
|
New perspectives on management of idiopathic pulmonary fibrosis, file dfe4d227-9869-bb0a-e053-d805fe0a78d9
|
14
|
|
Role of imaging in progressive-fibrosing interstitial lung diseases, file dfe4d22b-7218-bb0a-e053-d805fe0a78d9
|
14
|
|
Morphological patterns of sarcoidosis and clinical outcome: Retrospective analysis through a multidisciplinary approach, file dfe4d22d-845c-bb0a-e053-d805fe0a78d9
|
14
|
|
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies, file 295bfc0b-78d6-460d-895f-624ca904d80e
|
13
|
|
Cystic Interstitial Lung Diseases: A Pictorial Review and a Practical Guide for the Radiologist, file dc467a9c-6801-4938-8e68-27b139691fc8
|
13
|
|
Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction, file dfe4d226-f88b-bb0a-e053-d805fe0a78d9
|
13
|
|
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study, file dfe4d22b-75b4-bb0a-e053-d805fe0a78d9
|
13
|
|
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis, file dfe4d22b-7a84-bb0a-e053-d805fe0a78d9
|
13
|
|
Anti-inflammatory and antifibrotic effects of resveratrol in the lung., file dfe4d22b-8475-bb0a-e053-d805fe0a78d9
|
13
|
|
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis, file dfe4d22b-dfd8-bb0a-e053-d805fe0a78d9
|
13
|
|
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19, file b4a8ea59-2d92-4545-b207-52423d56acb9
|
12
|
|
Clinical and radiological features of extra-pulmonary sarcoidosis: a pictorial essay, file dfe4d22a-c3f2-bb0a-e053-d805fe0a78d9
|
12
|
|
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement, file dfe4d22b-87d0-bb0a-e053-d805fe0a78d9
|
12
|
|
Quantification of ground glass opacities can be useful to describe disease activity in systemic sclerosis, file dfe4d22e-2fc8-bb0a-e053-d805fe0a78d9
|
12
|
|
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies, file e33d15a5-4104-4eb7-bf13-cf7349607aa2
|
12
|
|
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis, file 244572b8-33d8-4535-9824-fecb6c767518
|
11
|
|
Lung dysfunction and increased arterial stiffness: causality or epiphenomenon?, file 31188b47-990e-40cf-8a22-a92b4875fff3
|
11
|
|
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study, file 3957a959-1afd-4edb-b3b8-e0deb12e76b2
|
11
|
|
Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors, file 425fcbac-d838-496e-9bfd-f55e053173a5
|
11
|
|
16,16-Dimethyl Prostaglandin E2 Efficacy on Prevention and Protection from Bleomycin-induced Lung Injury and Fibrosis, file c6a6ba9a-95b8-4bc2-a5b4-1b5a9d6d9633
|
11
|
|
Conditioned Media From Glial Cells Promote a Neural-Like Connexin Expression in Human Adipose-Derived Mesenchymal Stem Cells, file dfe4d229-7f84-bb0a-e053-d805fe0a78d9
|
11
|
|
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments, file dfe4d22b-5696-bb0a-e053-d805fe0a78d9
|
11
|
|
Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: Results from a prospective cohort study in the Sicilian general practice setting, file dfe4d22b-8148-bb0a-e053-d805fe0a78d9
|
11
|
|
Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries, file dfe4d22b-9c41-bb0a-e053-d805fe0a78d9
|
11
|
|
Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch, file dfe4d22b-9c44-bb0a-e053-d805fe0a78d9
|
11
|
|
Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study, file dfe4d22b-c29d-bb0a-e053-d805fe0a78d9
|
11
|
|
The European IPF registry (eurIPFreg): Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis, file dfe4d22b-e4b9-bb0a-e053-d805fe0a78d9
|
11
|
|
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist, file dfe4d22c-2e62-bb0a-e053-d805fe0a78d9
|
11
|
|
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology, file dfe4d226-fc12-bb0a-e053-d805fe0a78d9
|
10
|
|
Circulating fibrocytes as a marker of liver fibrosis in chronic hepatitis C, file dfe4d227-b41d-bb0a-e053-d805fe0a78d9
|
10
|
|
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances, file dfe4d22b-7f87-bb0a-e053-d805fe0a78d9
|
10
|
|
Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea, file 2a15924a-febb-4b6e-893f-ad79a22d565b
|
9
|
|
Pulmonary Vasculitides: A Radiological Review Emphasizing Parenchymal HRCT Features, file 9ebfa618-20f1-4268-befd-33fd1534a5ba
|
9
|
|
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course, file bbb94098-90e6-437c-b347-c745bc5fc62e
|
9
|
|
The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis., file dfe4d22a-bd2a-bb0a-e053-d805fe0a78d9
|
9
|
|
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis, file dfe4d22d-ec0d-bb0a-e053-d805fe0a78d9
|
9
|
|
Sleep quality and mental health during the COVID-19 pandemic in patients with severe obstructive sleep apnea, file b67a457c-8e8c-4e9a-ab38-eb20931a33e0
|
8
|
|
Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): a pictorial review, file dfe4d227-9dce-bb0a-e053-d805fe0a78d9
|
8
|
|
Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients' perspectives of the disease and treatment., file dfe4d22b-1f53-bb0a-e053-d805fe0a78d9
|
8
|
|
When to start and when to stop antifibrotic therapies, file dfe4d22b-71fe-bb0a-e053-d805fe0a78d9
|
8
|
|
Circulating fibrocytes as a marker of liver fibrosis in chronic hepatitis C, file dfe4d22e-b77f-bb0a-e053-d805fe0a78d9
|
8
|
|
Lung Segmentation on High-Resolution Computerized Tomography Images Using Deep Learning: A Preliminary Step for Radiomics Studies, file 1917f828-748b-4987-a62f-4ed78df23ec8
|
7
|
|
Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms, file 762b3e09-0dd0-43f5-b645-fdbbb6290ed3
|
7
|
|
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study, file ca832eec-6592-460a-ab4b-27af1a78cdd3
|
7
|
|
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?, file dba163ce-35d8-4ee8-8484-103f8f425c58
|
7
|
|
Glia mediates the neuroprotective action of estradiol on {beta}-amyloid-induced neuronal death, file dfe4d226-f7dc-bb0a-e053-d805fe0a78d9
|
7
|
|
Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis, file dfe4d22e-3e99-bb0a-e053-d805fe0a78d9
|
7
|
|
Multidisciplinary approach to interstitial lung diseases: Nothing is better than all of us together, file dfe4d22e-4194-bb0a-e053-d805fe0a78d9
|
7
|
|
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP), file dfe4d22e-7608-bb0a-e053-d805fe0a78d9
|
7
|
|
Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study, file dfe4d22e-89c0-bb0a-e053-d805fe0a78d9
|
7
|
|
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak, file dfe4d22e-dd88-bb0a-e053-d805fe0a78d9
|
7
|
|
Resumption of respiratory outpatient services in the COVID-19 era: Experience from Southern Italy, file 005c5655-7c3e-42ef-8ca3-70a4ae4ce498
|
6
|
|
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials, file 13b02deb-5be9-4dce-9407-13729469d281
|
6
|
|
Malnutrition in idiopathic pulmonary fibrosis: The Great Forgotten Comorbidity!, file 4b2f8b7e-b162-4e7b-ad80-71e5c5053e89
|
6
|
|
Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis, file 696e690b-9527-40cf-af79-4964d3e2b86a
|
6
|
|
Acute exacerbation of idiopathic pulmonary fibrosis: International survey and call for harmonisation, file 7c427849-9d8c-4749-ac8a-3e0578fc2631
|
6
|
|
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review, file 854cbd0b-e57e-44e4-b05a-476eeb091c20
|
6
|
|
Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification, file 876a16cb-d413-4b55-8f40-6a506e57fe6d
|
6
|
|
Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes, file be2e7e7c-d0d4-4aa4-83b7-e18346229736
|
6
|
|
A progression-free end-point for idiopathic pulmonary fibrosis trials: lessons from cancer, file befc4bb2-9bdb-417a-ac2f-bca582495623
|
6
|
|
Calcineurin inhibitor-based immunosuppression and COVID-19: Results from a multidisciplinary cohort of patients in Northern Italy, file c9a1e092-8353-442d-b023-c1dde3c67aa9
|
6
|
|
Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced lung fibrosis, file ce07c3d8-8541-4a27-9185-2d89e762f223
|
6
|
|
Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells, file df83e2a9-279c-4283-89d9-906475f9f9b3
|
6
|
|
Cough in idiopathic pulmonary fibrosis., file dfe4d22b-8a66-bb0a-e053-d805fe0a78d9
|
6
|
|
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?, file dfe4d22b-a865-bb0a-e053-d805fe0a78d9
|
6
|
|
Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury, file 050f0753-8f15-4138-9638-2a43e7475c42
|
5
|
|
Subsegmental pulmonary embolism: value of thoracic ultrasound for diagnosis and follow-up, file 0ed6365a-30ce-4ad4-8870-7d0d8ba03c44
|
5
|
|
Prevalence and clinical features of most frequent phenotypes in the Italian COPD population: The CLIMA study, file 4163b921-e7d6-429a-a7a9-e6fdbbb30866
|
5
|
|
Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting, file 6ecb2ed5-2ceb-4ff4-9eb4-f4be72b93dd4
|
5
|
|
Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study, file 8d085fc7-c5f8-4031-a512-383f72131e59
|
5
|
|
Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients, file 9bbae005-a3c2-40b3-a1bf-e6c840dc5d6f
|
5
|
|
Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good, file 9c000b8b-3c26-4004-83ff-663f8b2162b3
|
5
|
|
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State, file b83fa1bd-59d0-4c8c-ad8d-bbab86de1196
|
5
|
|
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study, file c03caa1e-7a9e-4a17-98ee-86d2e415f2b6
|
5
|
| Totale |
4.399 |